Export Snapshot

Minimum order

1 Centimetre

HSN Code

On request

Origin

India

Lead time

On request

Port of dispatch

On request

Packaging

Standard export packaging

Shelf life / storage

As per product specification

Export markets served

DZ AD AI AO AR +47 others

Ability to customise

As per OEM brief

Values shown are for Melizza Lifescience.

Company Melizza Lifescience

Melizza Lifescience

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals › Drugs & Pharmaceuticals.

View profile →

Established

Not shared

Employees

–

GST

24GQFPM5460R1Z4

IEC code

GQFPM5460R

Export markets

DZ AD AI AO AR +47 others

Member since

Aug 2025

Turnover

On request

Incorporation type

On request

Product details

Dosage & Administration:

• Administered as intravenous infusion only.

• 5 mg once yearly (for osteoporosis).

• 4 mg every 3–4 weeks (for oncology indications such as bone metastases).

• Dose and frequency depend on indication and patient’s renal function.

(Must be given by a healthcare professional under strict supervision.)

Key Benefits:

• Reduces risk of fractures and bone complications in cancer patients.

• Long-lasting bone protection with infrequent dosing.

• Effective in lowering high calcium levels caused by tumors.

Packaging:

• Single-dose vial: 100 mL solution containing 5 mg Zoledronic Acid.

Storage:

• Store below 30°C.

• Do not freeze.

• Protect from light.

Important Notes:

• For hospital/oncology use only.

• Not recommended in patients with severe kidney impairment.

• Adequate hydration before and after infusion is essential.

• Calcium and vitamin D supplementation may be required during treatment.

ONCOLOGY SUPPLIER

Melizza Lifescience

Description provided by Melizza Lifescience.

Zoledronic Acid 5 mg per 100 mL

Intravenous Injection

Oncology and Bone Health (Bisphosphonate)

Hypercalcemia of malignancy, bone metastases, multiple myeloma, osteoporosis, Paget’s disease

5 mg once yearly (osteoporosis), 4 mg every 3-4 weeks (oncology)

Inhibits osteoclast activity to reduce bone resorption and calcium release

Single-dose vial containing 100 mL solution

Store below 30°C, do not freeze, protect from light

Intravenous infusion by healthcare professional

Not recommended for severe kidney impairment; requires hydration and possible supplementation

Specifications

Generic Name

Zoledronic Acid

Brand Name

Gemdronic 5mg

Concentration

5 mg/100 mL

Formulation Type

Sterile injectable solution

Therapeutic Category

Bisphosphonate for Oncology and Bone Disorders

Route of Administration

Intravenous infusion

Shelf Life

Refer to product packaging/manufacturer guidelines

Manufacturer

Marketed under various oncology and critical care brands

Usage Restrictions

For hospital/oncology use only

Precautions

Monitor renal function; ensure adequate hydration; vitamin D and calcium supplementation recommended

Use cases

Category

Pharmaceuticals > Oncological Drugs > Bone Modifying Agents > Bisphosphonates

Primary application

Brand

Not specified

Product type

Product

Logistics & handling

Lead time

On request

Packaging

As per buyer requirement

Storage condition

As recommended by supplier

Origin

India

Form

As listed by supplier

Commercials Melizza Lifescience

Minimum order

1 Centimetre

Lead time

On request

Payment terms

As per negotiated commercial agreement

Frequently asked by buyers

Can Gemdronic 5mg be used in patients with severe renal impairment?

Gemdronic 5mg is not recommended for patients with severe kidney impairment due to the risk of adverse effects; renal function must be assessed before administration.

What is the recommended frequency of Gemdronic 5mg administration for osteoporosis?

For osteoporosis, Gemdronic 5mg is typically administered as a 5 mg intravenous infusion once yearly under medical supervision.

How does Gemdronic 5mg help in managing bone metastases in cancer patients?

Gemdronic 5mg inhibits osteoclast-mediated bone resorption, reducing skeletal complications such as fractures and lowering elevated calcium levels caused by bone metastases.

Are calcium and vitamin D supplementation necessary during treatment with Gemdronic 5mg?

Yes, calcium and vitamin D supplementation are often recommended to support bone health and reduce the risk of hypocalcemia during treatment.

Is Gemdronic 5mg suitable for outpatient treatment or restricted to hospital use?

Gemdronic 5mg is intended for hospital or oncology center use only and must be administered by healthcare professionals through intravenous infusion.

Question not answered? Sellers typically reply within 24–48 hours. Ask a question

What similar products are available in this category?

Browse all →

surbhi herbal tea - an ayurvedic formulation

Hetha

From $ 5.44

MOQ 1 Centimetre

brahmi ghrita nasal drop

Hetha

From $ 5.10

MOQ 1 Centimetre

himalayan badri gaumutra (gomutra) ark

Hetha

From $ 3.97

MOQ 1 Centimetre

triphala gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

desi cow gaumutra ark / gomutra ark

Hetha

From $ 3.40

MOQ 1 Centimetre

parijat aloevera gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

kachnar gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

tulsi giloy gaumutra ark

Hetha

From $ 3.97

MOQ 1 Centimetre

More from Melizza Lifescience